UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6

Molecular cancer, 2015-03, Vol.14 (1), p.57-57, Article 57

2015

Volltextzugriff (PDF)

Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest

BMC cancer, 2015-10, Vol.15 (1), p.682-682, Article 682

2015

Volltextzugriff (PDF)

Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis

Journal of ovarian research, 2021-11, Vol.14 (1), p.156-156, Article 156

2021

Volltextzugriff (PDF)

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer

The Journal of clinical investigation, 2016-11, Vol.126 (11), p.4157-4173

2016

Volltextzugriff (PDF)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Frontiers in immunology, 2020-10, Vol.11, p.577869

2020

Volltextzugriff (PDF)

Therapeutic applications of PARP inhibitors in ovarian cancer

Biomedicine & pharmacotherapy, 2020-07, Vol.127, p.110204-110204, Article 110204

2020

Volltextzugriff (PDF)

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

The lancet oncology, 2023-10, Vol.24 (10), p.1134-1146

2023

Volltextzugriff (PDF)

Patients' perceptions of service quality in China: An investigation using the SERVQUAL model

PloS one, 2017-12, Vol.12 (12), p.e0190123-e0190123

2017

Volltextzugriff (PDF)

Large‐scale profiling of metabolic dysregulation in ovarian cancer

International journal of cancer, 2015-02, Vol.136 (3), p.516-526

2015

Volltextzugriff (PDF)

Hypoxic tumour-derived exosomal miR-1225-5p regulates M2 macrophage polarisation via toll-like receptor 2 to promote ovarian cancer progress

Autoimmunity (Chur, Switzerland), 2023-12, Vol.56 (1), p.2281226-2281226

2023

Volltextzugriff (PDF)

Upregulation of miR‐874‐3p and miR‐874‐5p inhibits epithelial ovarian cancer malignancy via SIK2

Journal of biochemical and molecular toxicology, 2018-08, Vol.32 (8), p.e22168-n/a

2018

Volltextzugriff (PDF)

Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics

Scientific reports, 2020-04, Vol.10 (1), p.7315, Article 7315

2020

Volltextzugriff (PDF)

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Frontiers in immunology, 2021-07, Vol.12, p.697083-697083

2021

Volltextzugriff (PDF)

Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer

The International journal of biological markers, 2020-03, Vol.35 (1), p.65-73

2020

Volltextzugriff (PDF)

Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated With Platinum Resistance in Epithelial Ovarian Cancer

International journal of gynecological cancer, 2018-02, Vol.28 (2), p.323-331

2018

Volltextzugriff (PDF)

MicroRNA‐124: An emerging therapeutic target in cancer

Cancer medicine (Malden, MA), 2019-09, Vol.8 (12), p.5638-5650

2019

Volltextzugriff (PDF)

CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells

Biomedicine & pharmacotherapy, 2023-05, Vol.161, p.114529-114529, Article 114529

2023

Volltextzugriff (PDF)

Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

BMC medicine, 2024-05, Vol.22 (1), p.199-199, Article 199

2024

Volltextzugriff (PDF)

MicroRNA-302b Suppresses Human Epithelial Ovarian Cancer Cell Growth by Targeting RUNX1

Cellular physiology and biochemistry, 2014-01, Vol.34 (6), p.2209-2220

2014

Volltextzugriff (PDF)

A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma

Nature communications, 2022-12, Vol.13 (1), p.7581-7581, Article 7581

2022

Volltextzugriff (PDF)

UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells

Journal of ovarian research, 2016-07, Vol.9 (1), p.42-42, Article 42

2016

Volltextzugriff (PDF)

Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003831

2022

Volltextzugriff (PDF)

Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling

Journal of proteome research, 2013-01, Vol.12 (1), p.505-512

2013

Volltextzugriff (PDF)

Multiple genome analyses reveal key genes in Vitamin C and Vitamin D synthesis and transport pathways are shared

Scientific reports, 2019-11, Vol.9 (1), p.16811-12, Article 16811

2019

Volltextzugriff (PDF)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1

Oncotarget, 2016-12, Vol.7 (52), p.87091-87099

2016

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(209)

Publikationsform

Artikel
(251)
Tagungsberichte
(1)

Sprache

Englisch
(239)
Chinesisch
(13)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6

Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest

Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis

Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Therapeutic applications of PARP inhibitors in ovarian cancer

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Patients' perceptions of service quality in China: An investigation using the SERVQUAL model

Large‐scale profiling of metabolic dysregulation in ovarian cancer

Hypoxic tumour-derived exosomal miR-1225-5p regulates M2 macrophage polarisation via toll-like receptor 2 to promote ovarian cancer progress

Upregulation of miR‐874‐3p and miR‐874‐5p inhibits epithelial ovarian cancer malignancy via SIK2

Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics

Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential

Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer

Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated With Platinum Resistance in Epithelial Ovarian Cancer

MicroRNA‐124: An emerging therapeutic target in cancer

CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells

Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer

MicroRNA-302b Suppresses Human Epithelial Ovarian Cancer Cell Growth by Targeting RUNX1

A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma

UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells

Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study

Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling

Multiple genome analyses reveal key genes in Vitamin C and Vitamin D synthesis and transport pathways are shared

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1

Aktive Filter

Suchergebnisse filtern